Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Farber, MD
University of North Carolina
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Guy'S and St. Thomas' Nhs Foundation Trust
London, United Kingdom
- St. Mary'S Hospital, Imperial College Healthcare, Nhs Trust
London, United Kingdom
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Keck Medical Center of Usc
Los Angeles, California, United States
- Kaiser Permanente San Francisco Medical Center
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Medstar Health Research Institute - Medstar Washington Hospital
Washington D.C., District of Columbia, United States
- University of Florida - Gainesville
Gainesville, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan - Cardiac Surgery
Ann Arbor, Michigan, United States
- Essentia Health
Duluth, Minnesota, United States
- Division of Vascular Surgery - Minneapolis Heart Institute
Minneapolis, Minnesota, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Mount Sinai West
New York, New York, United States
- Weill Cornell Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Sanger Heart & Vascular Institute
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Upp Heart and Vascular Institute
Pittsburgh, Pennsylvania, United States
- University of Tennessee -University Vascular Surgeons
Knoxville, Tennessee, United States
- St. David'S Healthcare
Austin, Texas, United States
- Baylor Heart & Vascular Hospital
Dallas, Texas, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- the Methodist Hospital - Houston
Houston, Texas, United States
- University of Texas Health Science Center
Houston, Texas, United States
- Sentara Medical Group
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jun 2019
- Primary completion
- 4 Jan 2023
- Completion
- 31 Jan 2030
- Last update posted
- 5 Jun 2026
- Registered enrollment
- 102
- Registry id
- NCT03728985
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.